Cytokine regulation of mucin secretion in a human middle ear epithelial model

Cytokine

Volumn 41, Issue 1, 2008, Pages 38-43

  Samuel, Erica A ^a   Burrows, Amy ^a   Kerschner, Joseph E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Interleukin 1 ; Mucin; Otitis media; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MUCIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITHELIUM CELL; GEL PERMEATION CHROMATOGRAPHY; HEARING LOSS; HUMAN; HUMAN CELL; INCUBATION TIME; LIQUID SCINTILLATION COUNTING; OTITIS MEDIA; PRIORITY JOURNAL; SECRETION; STATISTICAL ANALYSIS; UPREGULATION;

ANTIBODIES; CELL LINE, TRANSFORMED; DOSE-RESPONSE RELATIONSHIP, DRUG; EAR, MIDDLE; EPITHELIAL CELLS; HEARING LOSS; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MUCINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 37449011787     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.10.009     Document Type: Article

References (29)

1. Bluestone C.D., and Klein J.O. Otitis media, atelectasis, and eustacian tube dysfunction. In: Bluestone C.D., Stool S.E., and Kenna M.A. (Eds). Pediatric otolaryngology (1996), WB Saunders Co, Philadelphia, PA 388-582
2. Seiden A.M., Tami T.A., Pensak M.L., and Cotton R.T. Otolaryngology: the essentials. Thieme Medical Publishers (2000) 44-59
3. Hall-Stoodley L., Hu F.Z., Gieseke A., Nistico L., Nguyen D., Hayes J., et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296 2 (2006) 202-211
4. Fitzgerald J.E., Green G.G., Stafford F.W., Birchall J.P., and Pearson J.P. Characterization of human middle ear mucus glycoprotein in chronic secretory otitis media. Clin Chim Acta 169 (1987) 281-297
5. Hutton D.A., Fogg F.J., Murty G., Birchall J.P., and Pearson J.P. Preliminary characterization of mucin from effusions of cleft palate patients. Otolaryngol Head Neck Surg 109 (1993) 1000-1006
6. Smirnova M.G., Birchall J.P., and Pearson J.P. In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol 122 (2002) 146-152
7. Dinarello C.A. Interleukin-1 and its biologically related cytokines. Adv Immunol 44 (1989) 153-205
8. Chonmaitree T., Patel J.A., Garofalo R., et al. Role of leukotrienne B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol, Rhinol Laryngol 105 (1996) 968-974
9. Juhn S.K., Garvis W.J., Lees C.J., Le C.T., and Kim C.S. Determining otitis media severity from middle ear fluid analysis. Ann Otol, Rhinol Laryngol 163 (1994) 43-45
10. Maxwell K.S., Fitzgerald J.E., Burleson J.A., Leonard G., Carpenter R., and Kreutzer D.L. Interleukin-8 expression in otitis media. Laryngoscope 104 (1994) 989-995
11. Yellon R.F., Doyle W.J., Whiteside T.L., Diven W.F., March A.R., and Fireman P. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch Otolaryngol-Head Neck Surg 121 (1995) 865-869
12. Kerschner J.E., Burrows A., and Meyer T.K. Chinchilla middle ear epithelial mucin gene expression in response to inflammatory cytokines. Arch Otolaryngol - HNS 130 (2004) 1163-1167
13. Kerschner J.E., Beste D.J., Lynch J.B., Fox M.C., and Kehl M.S. Interleukin-1 receptor antagonist as an adjunct in the treatment of otitis media. Laryngoscope 110 (2000) 1457-1461
14. Kerschner J.E., Meyer T.K., and Wohlfeill E. Middle ear epithelial mucin production in response to interleukin 1beta exposure in vitro. Otolaryngol-Head Neck Surg 129 1 (2003) 128-135
15. Kerschner J.E., Meyer T.K., Burrows A., and Yang C. Middle ear epithelial mucin production in response to interleukin-6 exposure in vitro. Cytokine 26 (2004) 30-36
16. Diamond G., Legarda D., and Ryan L.K. The innate immune response of the respiratory epithelium. Immunol Rev 173 (2000) 27-38
17. Kerschner J.E. Mucin gene expression in human middle ear epithelium. American Laryngological, Rhinological and Otological Society Thesis. Laryngoscope 117 9 (2007) 1666-1676
18. Norman J., Franz M., Messina J., et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117 (1995) 648-655
19. Arend W.P. Interleukin-1 receptor antagonist: a new member of the interleukin-1 family. J Clin Invest 88 (1991) 1445-1451
20. Dinarello C.A., and Thompson R.C. Blocking IL-1: interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 12 (1991) 404-410
21. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood 77 (1991) 1627-1652
22. Feldmann M., Brennan F.M., Williams R.O., Elliot M.J., and Maini R.N. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TN F alpha antibody therapy and its mechanism of action. J Inflamm 47 (1995-1996) 90-96
23. O'Riordan M.G., O'Riordan D.S., Molloy R.G., Mannick J.A., and Rodrick M.L. Dosage and timing of anti-TNF-alpha antibody treatment determines its effect of resistance to sepsis after injury. J Surg Res 64 (1996) 95-101
24. Wakabayashi G., Gelfand J.A., Burke J.F., Thompson R.C., and Dinarello C.A. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 5 (1991) 338-343
25. Bennet A.N., Peterson P., Zain A., Grumley J., Ranayi G., and Kirkham B. Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure. Rheumatology (2005) [Epub. May 3, 2005]
26. First D.E. Anakinra: review of recombinant human interleukin-1 receptor antagonist in treatment of rheumatoid arthritis. Clin Ther 26 12 (2004) 1960-1975
27. Travassos W.J., and Cheifetz A.S. Infliximab: use in inflammatory bowel disease. Curr Treat Options Gastroenterol 8 (2005) 187-196
28. Ars B., and Ars-Piret N. Morpho-functional partition of the middle ear cleft. Acta Oto-Rhino-Laryngol Belg 51 3 (1997) 181-184
29. Chun Y.M., Moon S.K., Lee H.Y., Webster P., Brackmann D.E., Rhim J.S., et al. Immortalization of normal adult human middle ear epithelial cells using a retrovirus containing th1e E6/E7 genes of human papillomavirus type 16. Ann Otol, Rhinol Laryngol 111 6 (2002) 507-517